Derivative Liabilities (Details) - USD ($) |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Nov. 28, 2023 |
Aug. 09, 2023 |
Dec. 31, 2022 |
|
| Derivative Liabilities [Line Items] | |||||
| Exercise price per share | $ 1.68 | $ 3.23 | $ 33.82 | ||
| Exercise price exceeds | $ 6,840 | ||||
| Warrants issuance (in Dollars) | $ 1,978,000 | ||||
| Derivative liabilities (in Dollars) | $ 58 | $ 75,381 | |||
| Public SPAC Warrants [Member] | |||||
| Derivative Liabilities [Line Items] | |||||
| Number of warrants (in Shares) | 11,500,000 | ||||
| Exercise price per share | $ 5.75 | ||||
| Share price | 4,370 | ||||
| Public Warrants [Member] | |||||
| Derivative Liabilities [Line Items] | |||||
| Exercise price per share | $ 0.01 |
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
| X | ||||||||||
- Definition Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|